FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Albert Baldwin

Research Profile

Chemicals & Drugs

Living Beings

Mouse

Physiology

Anatomy

Phenomena

Phosphorylation

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Jessica L Allen; Paul Armistead; Albert S Baldwin; Nazmim S Bhuiya; James Coghill; Corey Cutler; Allison M Deal; Amber Essenmacher; Matthew S Fore; Don A Gabriel; Todd Hoffert; Robert Irons; Kristy Richards; Jerome Ritz; Philip A Roehrs; Jonathan S Serody; Andrew Sharf; Thomas C Shea; Jenna Wooten; Stefanie Sarantopoulos
B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways.
Jessica E Hutti; Charles M Perou; Adam D Pfefferle; Sean C Russell; Mayukh Sircar; Albert S Baldwin
Oncogenic PI3K mutations lead to NF-κB-dependent cytokine expression following growth factor deprivation.
William C Comb; Jessica E Hutti; Lewis C Cantley; Patricia C Cogswell; Albert S Baldwin
p85α SH2 domain phosphorylation by IKK promotes feedback inhibition of PI3K and Akt in response to cellular starvation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Albert Baldwin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Jessica L Allen; Paul Armistead; Albert S Baldwin; Nazmim S Bhuiya; James Coghill; Corey Cutler; Allison M Deal; Amber Essenmacher; Matthew S Fore; Don A Gabriel; Todd Hoffert; Robert Irons; Kristy Richards; Jerome Ritz; Philip A Roehrs; Jonathan S Serody; Andrew Sharf; Thomas C Shea; Jenna Wooten; Stefanie Sarantopoulos
B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways.
Blood 2012;120(12):2529-36.
2012: Jessica E Hutti; Charles M Perou; Adam D Pfefferle; Sean C Russell; Mayukh Sircar; Albert S Baldwin
Oncogenic PI3K mutations lead to NF-κB-dependent cytokine expression following growth factor deprivation.
Cancer research 2012;72(13):3260-9.
2012: William C Comb; Jessica E Hutti; Lewis C Cantley; Patricia C Cogswell; Albert S Baldwin
p85α SH2 domain phosphorylation by IKK promotes feedback inhibition of PI3K and Akt in response to cellular starvation.
Molecular cell 2012;45(6):719-30.
2012: Albert S Baldwin
Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer.
Immunological reviews 2012;246(1):327-45.
2012: Jessica E Hutti; Albert S Baldwin; Lewis C Cantley; Adam W Cheely; Dmitri Kireev; Melissa A Porter; Xiaodong Wang; William P Janzen
Development of a high-throughput assay for identifying inhibitors of TBK1 and IKKε.
PloS one 2012;7(7):e41494.
2011: S J Stein; Albert S Baldwin
NF-κB suppresses ROS levels in BCR-ABL(+) cells to prevent activation of JNK and cell death.
Oncogene 2011;30(45):4557-66.
2011: Bert H O'Neil; William K Funkhouser; Benjamin F Calvo; Michael O Meyers; Hong Jin Kim; Richard M Goldberg; Stephen A Bernard; Laura Caskey; Allison M Deal; Fred Wright; Albert S Baldwin; Joel E Tepper
Nuclear factor κ-light chain-enhancer of activated B cells is activated by radiotherapy and is prognostic for overall survival in patients with rectal cancer treated with preoperative fluorouracil-based chemoradiotheraphy.
International journal of radiation oncology, biology, physics 2011;80(3):705-11.
2011: W C Comb; Patricia C Cogswell; Raquel Sitcheran; Albert S Baldwin
IKK-dependent, NF-κB-independent control of autophagic gene expression.
Oncogene 2011;30(14):1727-32.
2011: Amanda L Rinkenbaugh; Albert S Baldwin
Monoallelic deletion of NFKBIA in glioblastoma: when less is more.
Cancer cell 2011;19(2):163-5.
2010: Daniela S Bassères; Aaron Ebbs; Elena Levantini; Albert S Baldwin
Requirement of the NF-kappaB subunit p65/RelA for K-Ras-induced lung tumorigenesis.
Cancer research 2010;70(9):3537-46.
2010: E C Merkhofer; Patricia C Cogswell; Albert S Baldwin
Her2 activates NF-kappaB and induces invasion through the canonical pathway involving IKKalpha.
Oncogene 2010;29(8):1238-48.
2010: Mazhar Adli; Evan Merkhofer; Patricia Cogswell; Albert S Baldwin
IKKalpha and IKKbeta each function to regulate NF-kappaB activation in the TNF-induced/canonical pathway.
PloS one 2010;5(2):e9428.
2009: Carl F Raetzsch; Natasha L Brooks; J McKee Alderman; Kelli S Moore; Peter A Hosick; Simon Klebanov; Shizuo Akira; James E Bear; Albert S Baldwin; Nigel Mackman; Terry P Combs
Lipopolysaccharide inhibition of glucose production through the Toll-like receptor-4, myeloid differentiation factor 88, and nuclear factor kappa b pathway.
Hepatology (Baltimore, Md.) 2009;50(2):592-600.
2009: Brian K Bednarski; Albert S Baldwin; Hong Jin Kim
Addressing reported pro-apoptotic functions of NF-kappaB: targeted inhibition of canonical NF-kappaB enhances the apoptotic effects of doxorubicin.
PloS one 2009;4(9):e6992.
2008: Nancy C Moss; Ruhang Tang; Monte Willis; William E Stansfield; Albert S Baldwin; Craig H Selzman
Inhibitory kappa B kinase-beta is a target for specific nuclear factor kappa B-mediated delayed cardioprotection.
The Journal of thoracic and cardiovascular surgery 2008;136(5):1274-9.
2008: Willie Wilson; Albert S Baldwin
Maintenance of constitutive IkappaB kinase activity by glycogen synthase kinase-3alpha/beta in pancreatic cancer.
Cancer research 2008;68(19):8156-63.
2008: Raquel Sitcheran; William C Comb; Patricia C Cogswell; Albert S Baldwin
Essential role for epidermal growth factor receptor in glutamate receptor signaling to NF-kappaB.
Molecular and cellular biology 2008;28(16):5061-70.
2008: Brian K Bednarski; Xiaoyu Ding; Kavita Coombe; Albert S Baldwin; Hong J Kim
Active roles for inhibitory kappaB kinases alpha and beta in nuclear factor-kappaB-mediated chemoresistance to doxorubicin.
Molecular cancer therapeutics 2008;7(7):1827-35.
2008: Han C Dan; Matthew J Cooper; Patricia C Cogswell; Joseph A Duncan; Jenny P-Y Ting; Albert S Baldwin
Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK.
Genes & development 2008;22(11):1490-500.
2008: Han C Dan; Albert S Baldwin
Differential involvement of IkappaB kinases alpha and beta in cytokine- and insulin-induced mammalian target of rapamycin activation determined by Akt.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(11):7582-9.
2008: Ruhang Tang; Xi-Long Zheng; Thomas E Callis; William E Stansfield; Jiayin He; Albert S Baldwin; Dazhi Wang; Craig H Selzman
Myocardin inhibits cellular proliferation by inhibiting NF-kappaB(p65)-dependent cell cycle progression.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(9):3362-7.
2008: Kris A Steinbrecher; Eleana Harmel-Laws; Raquel Sitcheran; Albert S Baldwin
Loss of epithelial RelA results in deregulated intestinal proliferative/apoptotic homeostasis and susceptibility to inflammation.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(4):2588-99.
2008: Elizabeth A. Duncan; Christine A Goetz; Sarah J Stein; Katie J Mayo; Brian J Skaggs; Karl Ziegelbauer; Charles L Sawyers; Albert S Baldwin
IkappaB kinase beta inhibition induces cell death in Imatinib-resistant and T315I Dasatinib-resistant BCR-ABL+ cells.
Molecular cancer therapeutics 2008;7(2):391-7.
2008: Christine A Goetz; Albert S Baldwin
NF-kappaB pathways in the immune system: control of the germinal center reaction.
Immunologic research 2008;41(3):233-47.
2007: Shaival H Davé; Jeremy S Tilstra; Katsuyoshi Matsuoka; Fengling Li; Thomas Karrasch; Jennifer K Uno; Antonia R Sepulveda; Christian Jobin; Albert S Baldwin; Paul D Robbins; Scott Plevy
Amelioration of chronic murine colitis by peptide-mediated transduction of the IkappaB kinase inhibitor NEMO binding domain peptide.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(11):7852-9.
2007: Jialiang Wang; Hanbing An; Marty W Mayo; Albert S Baldwin; Jialiang Wang
LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB.
Cancer cell 2007;12(3):239-51.
2007: Han C Dan; Mazhar Adli; Albert S Baldwin
Regulation of mammalian target of rapamycin activity in PTEN-inactive prostate cancer cells by I kappa B kinase alpha.
Cancer research 2007;67(13):6263-9.
2007: Mileka R Gilbert; Diane G Carnathan; Patricia C Cogswell; Li Lin; Albert S Baldwin; Barbara J Vilen
Dendritic cells from lupus-prone mice are defective in repressing immunoglobulin secretion.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(8):4803-10.
2007: Swarnali Acharyya; S Armando Villalta; Nadine Bakkar; Tepmanas Bupha-Intr; Paul Janssen; Micheal Carathers; Zhi-Wei Li; Amer A Beg; Sankar Ghosh; Zarife Sahenk; Michael Weinstein; Katherine L Gardner; Jill A Rafael-Fortney; Michael Karin; James G Tidball; Albert S Baldwin; Denis C Guttridge
Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy.
The Journal of clinical investigation 2007;117(4):889-901.
2007: Pradip Sen; Mark A Wallet; Zuoan Yi; Yingsu Huang; Michael Henderson; Clayton E Mathews; Henry Earp; Glenn K Matsushima; Albert S Baldwin; Roland Tisch
Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells.
Blood 2007;109(2):653-60.
2007: Bert O Neil; Petra Bůzková; Hillary Farrah; David Kashatus; Hanna Sanoff; Richard M Goldberg; Albert S Baldwin; William K Funkhouser
Expression of nuclear factor-kappaB family proteins in hepatocellular carcinomas.
Oncology 2007;72(1-2):97-104.
2006: D S Bassères; Albert S Baldwin
Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression.
Oncogene 2006;25(51):6817-30.
2006: Mazhar Adli; Albert S Baldwin
IKK-i/IKKepsilon controls constitutive, cancer cell-associated NF-kappaB activity via regulation of Ser-536 p65/RelA phosphorylation.
The Journal of biological chemistry 2006;281(37):26976-84.
2006: Thomas Karrasch; Kris A Steinbrecher; Brigitte Allard; Albert S Baldwin; Christian Jobin
Wound-induced p38MAPK-dependent histone H3 phosphorylation correlates with increased COX-2 expression in enterocytes.
Journal of cellular physiology 2006;207(3):809-15.
2006: Elizabeth A. Duncan; Vasiliki Anest; Patricia C Cogswell; Albert S Baldwin
The kinases MSK1 and MSK2 are required for epidermal growth factor-induced, but not tumor necrosis factor-induced, histone H3 Ser10 phosphorylation.
The Journal of biological chemistry 2006;281(18):12521-5.
2006: Hong Jin Kim; N Hawke; Albert S Baldwin
NF-kappaB and IKK as therapeutic targets in cancer.
Cell death and differentiation 2006;13(5):738-47.
2006: David Kashatus; Patricia C Cogswell; Albert S Baldwin
Expression of the Bcl-3 proto-oncogene suppresses p53 activation.
Genes & development 2006;20(2):225-35.
2005: Kris A Steinbrecher; Willie Wilson; Patricia C Cogswell; Albert S Baldwin
Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription.
Molecular and cellular biology 2005;25(19):8444-55.
2005: Raquel Sitcheran; Pankaj Gupta; Paul B Fisher; Albert S Baldwin
Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNFalpha-controlled repression.
The EMBO journal 2005;24(3):510-20.
2004: Juan-Jose Ventura; Patricia C Cogswell; Richard A Flavell; Albert S Baldwin; Roger J Davis
JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species.
Genes & development 2004;18(23):2905-15.
2004: Julie L Hanson; Noel A Hawke; David Kashatus; Albert S Baldwin
The nuclear factor kappaB subunits RelA/p65 and c-Rel potentiate but are not required for Ras-induced cellular transformation.
Cancer research 2004;64(20):7248-55.
2004: Amy Loercher; Tin-Lap Lee; Justin L Ricker; April Howard; Joel Geoghegen; Zhong Chen; John B Sunwoo; Raquel Sitcheran; Eric Y Chuang; James B Mitchell; Albert S Baldwin; Carter Van Waes
Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.
Cancer research 2004;64(18):6511-23.
2004: Sandip Bhattacharyya; Pradip Sen; Mark A Wallet; Brian Long; Albert S Baldwin; Roland Tisch
Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the PI3K/Akt pathway and of IkappaB kinase activity.
Blood 2004;104(4):1100-9.
2004: Vasiliki Anest; Patricia C Cogswell; Albert S Baldwin
IkappaB kinase alpha and p65/RelA contribute to optimal epidermal growth factor-induced c-fos gene expression independent of IkappaBalpha degradation.
The Journal of biological chemistry 2004;279(30):31183-9.
2004: Elena Kurenova; Li-Hui Xu; Xihui Yang; Albert S Baldwin; Rolf J Craven; Steven K Hanks; Zheng-Gang Liu; William G Cance
Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein.
Molecular and cellular biology 2004;24(10):4361-71.
2003: Jefferson T Baer; Tracey V du Laney; Priscilla B Wyrick; Arlene S McCain; Thomas A Fischer; Elizabeth P Merricks; Albert S Baldwin; Timothy C Nichols
Nuclear factor-kappaB activation in endothelium by Chlamydia pneumoniae without active infection.
The Journal of infectious diseases 2003;188(8):1094-7.
2003: Raquel Sitcheran; Patricia C Cogswell; Albert S Baldwin
NF-kappaB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism.
Genes & development 2003;17(19):2368-73.
2003: Julie L Hanson; Vasiliki Anest; Julie Reuther-Madrid; Albert S Baldwin
Oncoprotein suppression of tumor necrosis factor-induced NF kappa B activation is independent of Raf-controlled pathways.
The Journal of biological chemistry 2003;278(37):34910-7.
2003: Vasiliki Anest; Julie L Hanson; Patricia C Cogswell; Kris A Steinbrecher; Brian D Strahl; Albert S Baldwin
A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression.
Nature 2003;423(6940):659-63.
2003: Joseph Pye; Farhad Ardeshirpour; Arlene McCain; Dwight A Bellinger; Elizabeth P Merricks; Julian Adams; Peter J Elliott; Christine S Pien; Thomas H Fischer; Albert S Baldwin; Timothy C Nichols
Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury.
American journal of physiology. Heart and circulatory physiology 2003;284(3):H919-26.
2003: Pradip Sen; Sandip Bhattacharyya; Mark A Wallet; Carmen P Wong; Brian Poligone; Maitreyee Sen; Albert S Baldwin; Roland Tisch
NF-kappa B hyperactivation has differential effects on the APC function of nonobese diabetic mouse macrophages.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(4):1770-80.
2003: Kyle D Weaver; Susan Yeyeodu; James C Cusack; Albert S Baldwin; Matthew G Ewend
Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas.
Journal of neuro-oncology 2003;61(3):187-96.
2003: Patricia C Cogswell; David Kashatus; Jayne A Keifer; Denis C Guttridge; Julie Y Reuther; Cindy Bristow; Sophie Roy; Donald W Nicholson; Albert S Baldwin
NF-kappa B and I kappa B alpha are found in the mitochondria. Evidence for regulation of mitochondrial gene expression by NF-kappa B.
The Journal of biological chemistry 2003;278(5):2963-8.
2003: Lee V Madrid; Albert S Baldwin
Regulation of NF-kappaB by oncoproteins and tumor suppressor proteins.
Methods in molecular biology (Clifton, N.J.) 2003;223():523-32.
2002: Robert Z Orlowski; Thomas E Stinchcombe; Beverly S Mitchell; Thomas C Shea; Albert S Baldwin; Stephanie Stahl; Julian Adams; Dixie Esseltine; Peter J Elliott; Christine S Pien; Roberto Guerciolini; Jessica K Anderson; Natalie D Depcik-Smith; Rita Bhagat; Mary Jo Lehman; steven novick; Owen A O'Connor; Steven L Soignet
Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(22):4420-7.
2002: Robert Z Orlowski; Albert S Baldwin
NF-kappaB as a therapeutic target in cancer.
Trends in molecular medicine 2002;8(8):385-9.
2002: Marty W Mayo; Lee V Madrid; Sandy Westerheide; David R Jones; Xiu-Juan Yuan; Albert S Baldwin; Young E Whang
PTEN blocks tumor necrosis factor-induced NF-kappa B-dependent transcription by inhibiting the transactivation potential of the p65 subunit.
The Journal of biological chemistry 2002;277(13):11116-25.
2002: Brian Poligone; Donald J Weaver; Pradip Sen; Albert S Baldwin; Roland Tisch
Elevated NF-kappaB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(1):188-96.
2001: Sandy Westerheide; Marty W Mayo; Vasiliki Anest; Julie L Hanson; Albert S Baldwin
The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G(1) transition.
Molecular and cellular biology 2001;21(24):8428-36.
2001: MQ Holmes-McNary; Albert S Baldwin; Steven H Zeisel
Opposing regulation of choline deficiency-induced apoptosis by p53 and nuclear factor kappaB.
The Journal of biological chemistry 2001;276(44):41197-204.
2001: Brian Poligone; Albert S Baldwin
Positive and negative regulation of NF-kappaB by COX-2: roles of different prostaglandins.
The Journal of biological chemistry 2001;276(42):38658-64.
2001: BP Ashburner; Sandy Westerheide; Albert S Baldwin
The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression.
Molecular and cellular biology 2001;21(20):7065-77.
2001: Donald J Weaver; Brian Poligone; T Bui; U M Abdel-Motal; Albert S Baldwin; Roland Tisch
Dendritic cells from nonobese diabetic mice exhibit a defect in NF-kappa B regulation due to a hyperactive I kappa B kinase.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(3):1461-8.
2001: J A Keifer; Denis C Guttridge; BP Ashburner; Albert S Baldwin
Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity.
The Journal of biological chemistry 2001;276(25):22382-7.
2001: Lee V Madrid; Marty W Mayo; J Y Reuther; Albert S Baldwin
Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38.
The Journal of biological chemistry 2001;276(22):18934-40.
2001: James C Cusack; R Liu; M Houston; K Abendroth; P J Elliott; J Adams; Albert S Baldwin
Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition.
Cancer research 2001;61(9):3535-40.
2001: Suzanne M Russo; Joel E Tepper; Albert S Baldwin; R Liu; J Adams; P Elliott; James C Cusack
Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB.
International journal of radiation oncology, biology, physics 2001;50(1):183-93.
2001: Albert S Baldwin
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
The Journal of clinical investigation 2001;107(3):241-6.
2001: Marty W Mayo; JL Norris; Albert S Baldwin
Ras regulation of NF-kappa B and apoptosis.
Methods in enzymology 2001;333():73-87.
2001: Albert S Baldwin
Series introduction: the transcription factor NF-kappaB and human disease.
The Journal of clinical investigation 2001;107(1):3-6.
2000: Dazhi Wang; Sandy Westerheide; Julie L Hanson; Albert S Baldwin
Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II.
The Journal of biological chemistry 2000;275(42):32592-7.
2000: Denis C Guttridge; Marty W Mayo; Lee V Madrid; Cun-Yu Wang; Albert S Baldwin
NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia.
Science (New York, N.Y.) 2000;289(5488):2363-6.
2000: Li-Hui Xu; X Yang; C A Bradham; David A Brenner; Albert S Baldwin; Rolf J Craven; William G Cance
The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells. Involvement of death receptor-related signaling pathways.
The Journal of biological chemistry 2000;275(39):30597-604.
2000: David R Jones; Robert Broad; Lee V Madrid; Albert S Baldwin; Marty W Mayo
Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis.
The Annals of thoracic surgery 2000;70(3):930-6; discussion 936-7.
2000: MQ Holmes-McNary; Albert S Baldwin
Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase.
Cancer research 2000;60(13):3477-83.
2000: James C Cusack; R Liu; Albert S Baldwin
Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothe cin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappaB activation.
Cancer research 2000;60(9):2323-30.
2000: Marty W Mayo; Albert S Baldwin
The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance.
Biochimica et biophysica acta 2000;1470(2):M55-62.
2000: Lee V Madrid; Cun-Yu Wang; Denis C Guttridge; Arndt Schottelius; Albert S Baldwin; Marty W Mayo
Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB.
Molecular and cellular biology 2000;20(5):1626-38.
2000: Patricia C Cogswell; Denis C Guttridge; William K Funkhouser; Albert S Baldwin
Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
Oncogene 2000;19(9):1123-31.
1999: Arndt Schottelius; Marty W Mayo; Ryan Sartor; Albert S Baldwin
Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding.
The Journal of biological chemistry 1999;274(45):31868-74.
1999: BP Ashburner; Rodney E Shackelford; Albert S Baldwin; Richard S Paules
Lack of involvement of ataxia telangiectasia mutated (ATM) in regulation of nuclear factor-kappaB (NF-kappaB) in human diploid fibroblasts.
Cancer research 1999;59(21):5456-60.
1999: C Y Wang; Denis C Guttridge; Marty W Mayo; Albert S Baldwin
NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis.
Molecular and cellular biology 1999;19(9):5923-9.
1999: R K Batra; Denis C Guttridge; David A Brenner; S M Dubinett; Albert S Baldwin; Richard C Boucher
IkappaBalpha gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitizes them to tumor necrosis factor-alpha-mediated cell death.
American journal of respiratory cell and molecular biology 1999;21(2):238-45.
1999: Denis C Guttridge; C Albanese; Julie Y Reuther; R G Pestell; Albert S Baldwin
NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.
Molecular and cellular biology 1999;19(8):5785-99.
1999: J Y Reuther; Albert S Baldwin
Apoptosis promotes a caspase-induced amino-terminal truncation of IkappaBalpha that functions as a stable inhibitor of NF-kappaB.
The Journal of biological chemistry 1999;274(29):20664-70.
1999: Marty W Mayo; C Y Wang; S S Drouin; Lee V Madrid; Allen Marshall; J C Reed; Bernard E Weissman; Albert S Baldwin
WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene.
The EMBO journal 1999;18(14):3990-4003.
1999: JL Norris; Albert S Baldwin
Oncogenic Ras enhances NF-kappaB transcriptional activity through Raf-dependent and Raf-independent mitogen-activated protein kinase signaling pathways.
The Journal of biological chemistry 1999;274(20):13841-6.
1999: William E Carson; H Yu; Julie Dierksheide; K Pfeffer; Page Bouchard; R Clark; Joan E Durbin; Albert S Baldwin; J Peschon; P R Johnson; G Ku; Heinz Baumann; Michael A Caligiuri
A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(8):4943-51.
1999: C Y Wang; James C Cusack; R Liu; Albert S Baldwin
Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB.
Nature medicine 1999;5(4):412-7.
1999: JL Cheshire; B R Williams; Albert S Baldwin
Involvement of double-stranded RNA-activated protein kinase in the synergistic activation of nuclear factor-kappaB by tumor necrosis factor-alpha and gamma-interferon in preneuronal cells.
The Journal of biological chemistry 1999;274(8):4801-6.
1999: Arndt Schottelius; Albert S Baldwin
A role for transcription factor NF-kappa B in intestinal inflammation.
International journal of colorectal disease 1999;14(1):18-28.
1998: Dazhi Wang; Albert S Baldwin
Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529.
The Journal of biological chemistry 1998;273(45):29411-6.
1998: C Y Wang; Marty W Mayo; R G Korneluk; D V Goeddel; Albert S Baldwin
NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.
Science (New York, N.Y.) 1998;281(5383):1680-3.
1998: William E Miller; JL Cheshire; Albert S Baldwin; Nancy Raab-Traub
The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells.
Oncogene 1998;16(14):1869-77.
1998: Julie Y Reuther; Gary W Reuther; D Cortez; Ann Marie Pendergast; Albert S Baldwin
A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation.
Genes & development 1998;12(7):968-81.
1997: Marty W Mayo; Cun-Yu Wang; Patricia C Cogswell; K S Rogers-Graham; Scott W Lowe; Channing J Der; Albert S Baldwin
Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras.
Science (New York, N.Y.) 1997;278(5344):1812-5.
1997: JL Cheshire; Albert S Baldwin
Synergistic activation of NF-kappaB by tumor necrosis factor alpha and gamma interferon via enhanced I kappaB alpha degradation and de novo I kappaBbeta degradation.
Molecular and cellular biology 1997;17(11):6746-54.
1997: T S Finco; John Westwick; JL Norris; A A Beg; Channing J Der; Albert S Baldwin
Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation.
The Journal of biological chemistry 1997;272(39):24113-6.
1997: AD Yurochko; Marty W Mayo; E E Poma; Albert S Baldwin; Eng-Shang Huang
Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters.
Journal of virology 1997;71(6):4638-48.
1997: Dazhi Wang; Marty W Mayo; Albert S Baldwin
Basic fibroblast growth factor transcriptional autoregulation requires EGR-1.
Oncogene 1997;14(19):2291-9.
1997: Patricia C Cogswell; Marty W Mayo; Albert S Baldwin
Involvement of Egr-1/RelA synergy in distinguishing T cell activation from tumor necrosis factor-alpha-induced NF-kappa B1 transcription.
The Journal of experimental medicine 1997;185(3):491-7.
1996: C Y Wang; Marty W Mayo; Albert S Baldwin
TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB.
Science (New York, N.Y.) 1996;274(5288):784-7.
1996: M Matsui; R J Warburton; Patricia C Cogswell; Albert S Baldwin; Jeffrey Frelinger
Effects of HIV-1 Tat on expression of HLA class I molecules.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;11(3):233-40.
1996: S S Makarov; John C Olsen; W N Johnston; S K Anderle; R R Brown; Albert S Baldwin; J Stephen Haskill; J H Schwab
Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(1):402-6.
1996: Albert S Baldwin
The NF-kappa B and I kappa B proteins: new discoveries and insights.
Annual review of immunology 1996;14():649-83.
1995: R I Scheinman; Patricia C Cogswell; A K Lofquist; Albert S Baldwin
Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids.
Science (New York, N.Y.) 1995;270(5234):283-6.
1995: C Y Ito; N Adey; Victoria L Bautch; Albert S Baldwin
Structure and evolution of the human IKBA gene.
Genomics 1995;29(2):490-5.
1995: T S Finco; Albert S Baldwin
Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis.
Immunity 1995;3(3):263-72.
1995: Antonio Gualberto; Albert S Baldwin
p53 and Sp1 interact and cooperate in the tumor necrosis factor-induced transcriptional activation of the HIV-1 long terminal repeat.
The Journal of biological chemistry 1995;270(34):19680-3.
1995: E Paine; R I Scheinman; Albert S Baldwin; Nancy Raab-Traub
Expression of LMP1 in epithelial cells leads to the activation of a select subset of NF-kappa B/Rel family proteins.
Journal of virology 1995;69(7):4572-6.
1995: Antonio Gualberto; Mary L Hixon; T S Finco; N D Perkins; Gary Nabel; Albert S Baldwin
A proliferative p53-responsive element mediates tumor necrosis factor alpha induction of the human immunodeficiency virus type 1 long terminal repeat.
Molecular and cellular biology 1995;15(6):3450-9.
1995: C R Toth; R F Hostutler; Albert S Baldwin; T P Bender
Members of the nuclear factor kappa B family transactivate the murine c-myb gene.
The Journal of biological chemistry 1995;270(13):7661-71.
1995: R I Scheinman; Antonio Gualberto; Christine M Jewell; John A Cidlowski; Albert S Baldwin
Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.
Molecular and cellular biology 1995;15(2):943-53.
1994: T S Finco; A A Beg; Albert S Baldwin
Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(25):11884-8.
1994: C Y Ito; A G Kazantsev; Albert S Baldwin
Three NF-kappa B sites in the I kappa B-alpha promoter are required for induction of gene expression by TNF alpha.
Nucleic acids research 1994;22(18):3787-92.
1994: A M Brown; Michael W Linhoff; B Stein; K L Wright; Albert S Baldwin; P V Basta; Jenny P-Y Ting
Function of NF-kappa B/Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-kappa B/Rel subunits.
Molecular and cellular biology 1994;14(5):2926-35.
1994: A A Beg; Albert S Baldwin
Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor.
Oncogene 1994;9(5):1487-92.
1994: D E Gutsch; Elizabeth Holley-Guthrie; Q Zhang; B Stein; M A Blanar; Albert S Baldwin; Shannon C Kenney
The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B.
Molecular and cellular biology 1994;14(3):1939-48.
1993: B Stein; Albert S Baldwin
Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B.
Molecular and cellular biology 1993;13(11):7191-8.
1993: A A Beg; Albert S Baldwin
The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors.
Genes & development 1993;7(11):2064-70.
1993: R I Scheinman; A A Beg; Albert S Baldwin
NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule.
Molecular and cellular biology 1993;13(10):6089-101.
1993: B Stein; Albert S Baldwin; D W Ballard; Warner Greene; P Angel; P Herrlich
Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function.
The EMBO journal 1993;12(10):3879-91.
1993: T S Finco; Albert S Baldwin
Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor kappa B requires Raf-1.
The Journal of biological chemistry 1993;268(24):17676-9.
1993: B Stein; Patricia C Cogswell; Albert S Baldwin
Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction.
Molecular and cellular biology 1993;13(7):3964-74.
1993: A A Beg; T S Finco; P V Nantermet; Albert S Baldwin
Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation.
Molecular and cellular biology 1993;13(6):3301-10.
1993: Patricia C Cogswell; R I Scheinman; Albert S Baldwin
Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(7):2794-804.
1993: Colin S Duckett; N D Perkins; T F Kowalik; Roland M Schmid; Eng-Shang Huang; Albert S Baldwin; Gary Nabel
Dimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3).
Molecular and cellular biology 1993;13(3):1315-22.
1993: Jenny P-Y Ting; Albert S Baldwin
Regulation of MHC gene expression.
Current opinion in immunology 1993;5(1):8-16.
1993: T F Kowalik; Bret Alan Wing; J Stephen Haskill; JC Azizkhan; Albert S Baldwin; Eng-Shang Huang
Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(3):1107-11.
1992: A A Beg; S M Ruben; R I Scheinman; S Haskill; C A Rosen; Albert S Baldwin
I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention.
Genes & development 1992;6(10):1899-913.
1991: Albert S Baldwin; JC Azizkhan; D E Jensen; A A Beg; L R Coodly
Induction of NF-kappa B DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts.
Molecular and cellular biology 1991;11(10):4943-51.
1991: S Haskill; A A Beg; Stephen M Tompkins; J S Morris; AD Yurochko; A Sampson-Johannes; K Mondal; P Ralph; Albert S Baldwin
Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity.
Cell 1991;65(7):1281-9.
1989: M A Blanar; Albert S Baldwin; R A Flavell; Phillip A Sharp
A gamma-interferon-induced factor that binds the interferon response sequence of the MHC class I gene, H-2Kb.
The EMBO journal 1989;8(4):1139-44.